CytomX Therapeutics, Inc. (CTMX)

CIK 1501989 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CytomX Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001907884-26-000014
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005484
Aug 7, 2026SCHEDULE 13G0000093751-26-000448
Aug 6, 202610-Q0001193125-26-337950
Aug 6, 20268-K0001193125-26-338009
Aug 6, 2026S-80001193125-26-338121
Aug 5, 202640001610717-26-000351
Aug 5, 202630001610717-26-000350
Aug 3, 2026SCHEDULE 13G0000070858-26-000395
Jul 30, 202630001610717-26-000344
Jul 30, 202640001610717-26-000345
Jul 27, 20268-K0001193125-26-316929
Jul 27, 2026SCHEDULE 13G0002012383-26-002247
Jun 22, 202640001610717-26-000279
Jun 22, 202640001610717-26-000280
Jun 22, 202640001610717-26-000274
Jun 22, 202640001610717-26-000277
Jun 22, 202640001610717-26-000276
Jun 22, 202640001610717-26-000275
Jun 22, 202640001610717-26-000278
Jun 22, 20268-K0001193125-26-277631
Jun 17, 202640001610717-26-000229
Jun 3, 20268-K0001193125-26-255467
May 15, 2026SCHEDULE 13G/A0001907884-26-000010
May 15, 2026SCHEDULE 13G/A0001193125-26-227057